JP2021514963A5 - - Google Patents

Info

Publication number
JP2021514963A5
JP2021514963A5 JP2020544648A JP2020544648A JP2021514963A5 JP 2021514963 A5 JP2021514963 A5 JP 2021514963A5 JP 2020544648 A JP2020544648 A JP 2020544648A JP 2020544648 A JP2020544648 A JP 2020544648A JP 2021514963 A5 JP2021514963 A5 JP 2021514963A5
Authority
JP
Japan
Prior art keywords
optionally substituted
groups
group
phenyl
triazinan
Prior art date
Application number
JP2020544648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021514963A (ja
JP7350759B2 (ja
JPWO2019162702A5 (https=
Filing date
Publication date
Priority claimed from GBGB1810667.4A external-priority patent/GB201810667D0/en
Application filed filed Critical
Priority claimed from PCT/GB2019/050523 external-priority patent/WO2019162702A1/en
Publication of JP2021514963A publication Critical patent/JP2021514963A/ja
Publication of JP2021514963A5 publication Critical patent/JP2021514963A5/ja
Publication of JPWO2019162702A5 publication Critical patent/JPWO2019162702A5/ja
Application granted granted Critical
Publication of JP7350759B2 publication Critical patent/JP7350759B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020544648A 2018-02-26 2019-02-26 ニューロトロフィンに関連する疾患を治療するためのトリアジン誘導体 Active JP7350759B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1850217-9 2018-02-26
SE1850217 2018-02-26
GB1810667.4 2018-06-28
GBGB1810667.4A GB201810667D0 (en) 2018-06-28 2018-06-28 New compounds and uses
PCT/GB2019/050523 WO2019162702A1 (en) 2018-02-26 2019-02-26 Triazine derivatives for treating diseases relating to neurotrophins

Publications (4)

Publication Number Publication Date
JP2021514963A JP2021514963A (ja) 2021-06-17
JP2021514963A5 true JP2021514963A5 (https=) 2022-03-07
JPWO2019162702A5 JPWO2019162702A5 (https=) 2022-03-07
JP7350759B2 JP7350759B2 (ja) 2023-09-26

Family

ID=65729389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020544648A Active JP7350759B2 (ja) 2018-02-26 2019-02-26 ニューロトロフィンに関連する疾患を治療するためのトリアジン誘導体

Country Status (24)

Country Link
US (3) US11352332B2 (https=)
EP (1) EP3759088B8 (https=)
JP (1) JP7350759B2 (https=)
KR (1) KR102782749B1 (https=)
CN (1) CN111819172B (https=)
AU (1) AU2019223333B2 (https=)
BR (1) BR112020017341A2 (https=)
CA (1) CA3090864A1 (https=)
CL (1) CL2020002157A1 (https=)
DK (1) DK3759088T3 (https=)
ES (1) ES2941529T3 (https=)
FI (1) FI3759088T3 (https=)
HR (1) HRP20230290T1 (https=)
HU (1) HUE061751T2 (https=)
IL (1) IL276624B2 (https=)
LT (1) LT3759088T (https=)
MA (1) MA52415A (https=)
MX (1) MX2020008816A (https=)
PL (1) PL3759088T3 (https=)
PT (1) PT3759088T (https=)
SG (1) SG11202007136VA (https=)
SI (1) SI3759088T1 (https=)
WO (1) WO2019162702A1 (https=)
ZA (1) ZA202004220B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102335292B1 (ko) * 2017-06-08 2021-12-06 닛뽕소다 가부시키가이샤 기록 재료 및 화합물
MA52415A (fr) 2018-02-26 2021-01-06 AlzeCure Pharma AB Dérivés de triazine pour le traitement de maladies associées à des neurotrophines
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
GB201912404D0 (en) * 2019-08-29 2019-10-16 AlzeCure Pharma AB New compounds
CN113831299B (zh) * 2020-06-23 2023-12-01 沈阳中化农药化工研发有限公司 苯甲酸酯类化合物及其应用
WO2021259224A1 (zh) * 2020-06-23 2021-12-30 沈阳中化农药化工研发有限公司 三嗪苯甲酸酯类化合物及其应用
CN113831298B (zh) * 2020-06-23 2023-12-01 沈阳中化农药化工研发有限公司 光活性羧酸酯类化合物及其应用
KR102770474B1 (ko) * 2021-03-23 2025-02-21 한국과학기술연구원 신규한 화합물 및 이를 포함하는 퇴행성 뇌질환 예방 또는 치료용 조성물
CN118216517B (zh) * 2022-12-21 2025-06-24 沈阳中化农药化工研发有限公司 一种除草组合物及其应用
WO2025232990A1 (en) 2024-05-09 2025-11-13 AlzeCure Pharma AB Triazinone derivatives for use in the treatment of inflammation

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246109A1 (de) 1972-09-20 1974-03-28 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazinderivate, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2313721A1 (de) * 1973-03-20 1974-10-03 Bayer Ag Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel
DE2413722C3 (de) * 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
CA1185974A (en) 1981-12-03 1985-04-23 Adolf Parg 1,3,5-triazinones and their use for controlling undesirable plant growth
DE3314739A1 (de) 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel
DE3408768A1 (de) * 1984-03-09 1985-09-12 Bayer Ag, 5090 Leverkusen Immunstimulierende mittel
DE3516632A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,3,5-triazintrionen
DE3516631A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 3-methyl-1,3,5-triazintrionen
DE3703105A1 (de) 1987-02-03 1988-08-11 Bayer Ag Mittel gegen protozoen bei insekten
DE3810080A1 (de) 1988-03-25 1989-10-05 Bayer Ag Trisubstituierte 1,3,5-triazin-2,4,6-trione
DE3814323A1 (de) 1988-04-28 1989-11-09 Hoechst Ag Wasserloesliche zubereitungen von coccidiostatica
US4933341A (en) 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
DE4000624A1 (de) 1990-01-11 1991-07-18 Bayer Ag Fungizide verwendung von trisubstituierten 1,3,5-triazin-2,4,6-trionen, neue trisubstituierte 1,3,5-triazin-2,4,6-trione und verfahren zu ihrer herstellung
DE4329096A1 (de) 1993-08-30 1995-03-02 Bayer Ag Heterocyclylbenzoheterocyclen
US5519133A (en) 1995-06-02 1996-05-21 American Cyanamid Co. 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents
US5726126A (en) 1995-06-02 1998-03-10 American Cyanamid Company 1-(3-heterocyclyphenyl)-S-triazine-2,6,6-oxo or thiotrione herbicidal agents
CZ146296A3 (en) 1995-06-02 1997-04-16 American Cyanamid Co 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotriones, process of their preparation and herbicidal agents
US5604180A (en) 1995-06-02 1997-02-18 Crews, Jr.; Alvin D. 3-(3-aryloxyphenyl)-1 (substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents
US5679791A (en) 1996-07-25 1997-10-21 American Cyanamid Company 1-(3-heterocyclylphenyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents
MXPA01003542A (es) 1998-10-08 2002-09-18 New Ace Res Company Composiciones y metodos nuevos para la prevencion y tratamiento de enfermedad causada por protozoarios.
AU2198100A (en) 1998-12-22 2000-07-12 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
DE19937500A1 (de) 1999-08-09 2001-02-15 Bayer Ag Substituierte Heterocyclylbenzofurane
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
US6444615B1 (en) 2000-04-18 2002-09-03 Dow Agrosciences Llc Herbicidal imidazolidinetrione and thioxo-imidazolidinediones
DE10034800A1 (de) 2000-07-18 2002-01-31 Bayer Ag Substituierte Benzostickstoffheterocyclen
DE10040110A1 (de) 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
DE10040174A1 (de) 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
WO2003029199A1 (en) 2001-09-28 2003-04-10 Takeda Chemical Industries, Ltd. Benzene derivatives, process for preparing the same and use thereof
US6861523B2 (en) 2002-02-08 2005-03-01 Torrey Pines Institute For Molecular Studies 1,3,5- trisubstituted-1,3,5-triazine-2,4,6-trione compounds and libraries
WO2003101980A1 (en) 2002-05-30 2003-12-11 Solvay Pharmaceuticals B.V. 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
US7241763B2 (en) 2002-07-15 2007-07-10 Janssen Pharmaceutica N.V. 3-furanyl analogs of toxoflavine as kinase inhibitors
DE102006038292A1 (de) 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
WO2008148008A1 (en) 2007-05-23 2008-12-04 Emory University High throughput bioassay for identifying selective trka receptor agonists, and gambogic amide, a selective trka agonist with neuroprotective activity
US20120004310A1 (en) 2010-05-28 2012-01-05 Longo Frank M Non-peptide bdnf neurotrophin mimetics
RU2015141934A (ru) 2013-03-15 2017-04-20 Фарматрофикс, Инк. Непептидные миметики нейротрофина bdnf
MX2016008842A (es) 2014-01-20 2016-11-08 Hoffmann La Roche Derivados de n-fenil-lactama capaces de estimular la neurogenesis y su uso en el tratamiento de trastornos neurologicos.
MX387871B (es) 2014-12-10 2025-03-19 Mars Inc Metodos para modular los receptores del gusto.
JP2020502225A (ja) 2016-12-21 2020-01-23 アルゼキュア ファーマ アーべー トリアジントリオン誘導体、ならびにニューロトロフィン受容体および受容体型チロシンキナーゼのモジュレーターとしてのその使用。
MA52415A (fr) 2018-02-26 2021-01-06 AlzeCure Pharma AB Dérivés de triazine pour le traitement de maladies associées à des neurotrophines
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
GB201810669D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
GB201912404D0 (en) 2019-08-29 2019-10-16 AlzeCure Pharma AB New compounds

Similar Documents

Publication Publication Date Title
JP2021514963A5 (https=)
IL276624B1 (en) Triazine derivatives for the treatment of neurotrophin-related diseases
US12404265B2 (en) Substituted pyridine derivatives as SARM1 inhibitors
JP5180834B2 (ja) 治療方法
JP2007519754A5 (https=)
CN102227423B (zh) 杀真菌杂环化合物
RU2419624C2 (ru) Сульфонамидные производные как активаторы гликокиназы, применимые для лечения диабета типа 2
TWI332948B (en) Pyrazoles as glucokinase activators
RU2480467C2 (ru) Производные изоксазола в качестве модуляторов 11-бета-гидроксистероиддегидрогеназы 1 типа
JP5788507B2 (ja) 置換3−フェニル−1,2,4−オキサジアゾール化合物
JP2005526723A5 (https=)
US11945796B2 (en) Substituted pyridine derivatives as SARM1 inhibitors
WO2003062233A1 (en) 2-acylaminothiazole derivative or salt thereof
JP2010533158A5 (https=)
JP2004502670A5 (https=)
JP2002505683A (ja) 複素環置換されたピペリジン類及びその使用
CN107001259B (zh) 作为taar配体的取代的氮杂环丁烷衍生物
HUP0200441A2 (hu) Tetrahidropiránszármazékok és terápiás szerként való alkalmazásuk és eljárás a vegyületek előállítására
JP2006506380A5 (https=)
US20210128528A1 (en) Use of 5ht2a inverse agonists for treating psychosis
JPWO2019162702A5 (https=)
JP2006502963A5 (https=)
EP1513836A1 (fr) Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
JP2021529168A5 (https=)
JP2007521312A5 (https=)